Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
3.150
+0.120 (3.96%)
At close: Nov 7, 2025, 4:00 PM EST
3.270
+0.120 (3.81%)
After-hours: Nov 7, 2025, 7:28 PM EST
Immix Biopharma Market Cap
Immix Biopharma has a market cap or net worth of $102.9 million as of November 7, 2025. Its market cap has increased by 129.96% in one year.
Market Cap
102.90M
Enterprise Value
88.05M
1-Year Change
129.96%
Ranking
Category
Stock Price
$3.15
Market Cap Chart
Since the IPO on December 16, 2021, Immix Biopharma's market cap has increased from $65.74M to $102.90M, an increase of 56.51%. That is a compound annual growth rate of 12.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 102.90M | 70.03% |
| Dec 31, 2024 | 60.52M | -55.98% |
| Dec 29, 2023 | 137.48M | 331.07% |
| Dec 30, 2022 | 31.89M | -32.18% |
| Dec 31, 2021 | 47.02M | -28.48% |
| Dec 16, 2021 | 65.74M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 845.70B |
| Johnson & Johnson | 448.73B |
| AbbVie | 375.98B |
| UnitedHealth Group | 294.02B |
| AstraZeneca | 253.45B |
| Novartis AG | 240.68B |
| Abbott Laboratories | 216.19B |
| Novo Nordisk | 215.64B |